Search the Newsreel

Claros Mortgage Trust, Inc. Reports Second Quarter 2026 Results

Claros Mortgage Trust, Inc. (CMTG) reported a GAAP net loss of $255.4 million ($1.81 per share) and a Distributable Loss of $90.8 million ($0.63 per share) for Q2 2026. Despite these losses, the company highlighted significant progress in resolving "watchlist" assets, deleveraging the balance …

Claros Mortgage Trust Q2 Results: Adj. EPS $(0.63) Misses Estimate

Claros Mortgage Trust reported a Q2 2026 GAAP net loss of $255.4 million, or $1.81 per share, primarily due to a substantial $208.8 million provision for credit losses, significantly missing analyst estimates for distributable loss. Despite this, the company made progress in resolving watchlist …

Claros Mortgage Trust : Second Quarter 2026 Earnings Supplement

Claros Mortgage Trust, Inc. (CMTG) reported a GAAP net loss of $255.4 million, or $1.81 per share, for the second quarter of 2026, primarily due to increased CECL reserves and losses from reclassified REO assets. The company's loan and REO portfolio stood at $2.8 …

Clarivate PLC (CLVT) Q2 2026 Earnings Call Highlights: Strategic Shifts and AI Innovations ...

This article first appeared on GuruFocus. Release Date: July 29, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Clarivate PLC (NYSE:CLVT) reported an improvement in organic Annual Contract Value (ACV) growth to 1.5% …

Clarivate (NYSE: CLVT) promotes Michael Easton to CFO role

Clarivate Plc announced the promotion of Michael Easton to Executive Vice President & Chief Financial Officer, effective August 8, 2026, following Jonathan Collins' resignation. Easton, previously Senior Vice President, Finance & Chief Accounting Officer, will receive a $600,000 base salary, 100% target annual bonus, …

Claros Mortgage Trust (NYSE: CMTG) takes $255M loss on rising reserves

Claros Mortgage Trust (CMTG) reported a GAAP net loss of $255.4 million, or $1.81 per share, for Q2 2026, primarily due to a $208.8 million provision for current expected credit loss reserves. The company's book value per share dropped to $8.58, down from $10.33 …

Claros Mortgage Trust reports $255.4 million quarterly net loss

Claros Mortgage Trust (CMTG) announced a GAAP net loss of $255.4 million, or $1.81 per share, for the quarter ending June 30, 2026. This loss was significantly impacted by a $208.8 million provision for CECL reserves. Despite the loss, the company reported increased liquidity …

First-half 2026 results

Clariane Half-Year Results: strong improvement in operating performance Successful refinancing transactions Objectives confirmed Strong improvement in operating performance Revenue as at 30 June 2026 stood at €2,699m, up +4.6% on an organic basis supported by volume growth of +1.6% and price gain of +3.0% …

RiskMark wins Best AI Tool For Lawyers at the 2026 CODiE awards

RiskMark, an AI-powered trademark risk assessment solution by Clarivate, has won the Best AI Tool for Lawyers at the 2026 CODiE Awards, following its 2025 LegalTech Breakthrough Award. The platform helps legal professionals assess the likelihood of confusion, identify potential trademark conflicts, and develop …

Earnings call transcript: Clarivate posts mixed Q2 2026 results as shares fall

Clarivate Plc Q2 2026 Earnings Call Summary - Moby Strategic Execution and Portfolio Optimization Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here. …

Clarivate (CLVT) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Clarivate PLC (CLVT) reported $587.3 million in revenue for the quarter ended June 2026, representing a year-over-year decline of 5.5%. EPS of $0.19 for the same period compares to $0.18 a year ago. The reported revenue compares to the Zacks Consensus Estimate of $587.06 …

Clarivate Releases Q2 2026 Financial Results

Clarivate Plc (CLVT) announced its Q2 2026 financial results, reporting an adjusted diluted EPS of $0.19, surpassing analyst estimates. The company generated $587.3M in revenue, a 5.5% year-over-year decrease, with organic ACV growth of 1.5%. Clarivate provided FY 2026 guidance, projecting adjusted EPS between …

Clarivate PLC (CLVT) Q2 Earnings and Revenues Beat Estimates

Clarivate PLC (CLVT) reported strong Q2 results, with earnings of $0.19 per share surpassing the Zacks Consensus Estimate of $0.17 and revenues of $587.3 million beating expectations by 0.04%. Despite these beats and positive past performance in exceeding EPS estimates, Clarivate's stock has declined …

Clarivate appoints Michael Easton as chief financial officer

Clarivate Plc has appointed Michael Easton as its new Executive Vice President and Chief Financial Officer, effective August 8, 2026. Easton, who currently serves as Clarivate's Senior Vice President and Chief Accounting Officer, brings over 25 years of experience in finance. He will replace …

Clarivate PLC 2026: Revenue $587.3M, EPS ($0.42) — 10-Q Summary

Clarivate PLC reported its Q2 2026 results, showing a decline in revenue to $587.3M from $621.4M in the prior year, and an increased net loss resulting in an EPS of ($0.42) compared to ($0.11) previously. Key factors included product wind-downs, lower transactional activity, and …

Clarivate Plc 2026 Q2 - Results - Earnings Call Presentation (NYSE:CLVT) 2026-07-29

Clarivate Plc (NYSE:CLVT) published its Q2 2026 earnings call presentation on July 29, 2026. The company reported an EPS of $0.19, beating estimates by $0.01, and revenue of $587.30M, which missed estimates by $2.46M and represented a 5.49% year-over-year decrease. The presentation was released …

Clarivate Analytics Non-GAAP EPS of $0.19 beats by $0.01, revenue of $587.3M misses by $2.46M

* Clarivate Analytics press release [https://seekingalpha.com/pr/20598844-clarivate-reports-second-quarter-2026-results] (CLVT [https://seekingalpha.com/symbol/CLVT]): Q2 Non-GAAP EPS of $0.19 beats by $0.01. * Revenue of $587.3M (-5.5% Y/Y) misses by $2.46M. * 2026 outlook (reaffirmed): * Adjusted diluted EPS: $0.70–$0.80 (vs. consensus of $0.73) * Revenue (including discontinued operations): $2.30B–$2.42B …

CLARIVATE earnings beat by $0.01, revenue fell short of estimates

CLVT|Clarivate PLC|Price:1.820|Chg%:-0.040

Clarivate Q2 Earnings Call Highlights

This article first appeared on GuruFocus. Release Date: July 29, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Clarivate PLC (NYSE:CLVT) reported an improvement in organic Annual Contract Value (ACV) growth to 1.5% …

Clarivate Shares Slip After Mixed Second-Quarter Results Despite Earnings Beat

Claros Mortgage Trust, Inc. (NYSE: CMTG) hit by $309.7M half-year loss

Claros Mortgage Trust Resolves $409.5M in Loans After Q2 Results

Claros Mortgage Trust (CMTG) Earnings Date and Reports 2026

Clarus Corp (CLAR) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Clarus Corp (CLAR), detailing its current price momentum, support and resistance levels, and performance across various technical indicators and moving averages. While the overall technical signal is Neutral, the stock is identified as suitable for range-bound swing …

Clarivate Reports Second Quarter 2026 Results

Clarivate Plc reported its second quarter 2026 results, showing continued progress on its strategic and financial priorities through its Value Creation Plan. The company reaffirmed its full-year 2026 financial outlook, anticipating ACV Organic Growth between 2.0% and 3.0% and Adjusted EBITDA of $980M to …

Clarivate Number of Employees 2026 | Employee Count & Headcount Data

Clarivate Plc (CLVT) had approximately 12,120 employees worldwide as of March 2026, marking a 3.5% growth from 2023 but a 0.8% decline year over year. The company's workforce is primarily concentrated in India, the United States, and Serbia, with an average salary of $54,277 …

Aclaris Therapeutics Market Sentiment

This article provides an overview of market sentiment for Aclaris Therapeutics (ACRS), highlighting key signals such as analyst consensus, short interest, options flow, and insider activity. Analysts show an "Outperform" consensus with an average price target significantly above the current price, while short interest …

Aclaris Therapeutics Inc (ACRS) Financial Health: Profitability & Balance Sheet Analysis

Aclaris Therapeutics Inc (ACRS) has a weak financial status and low operating efficiency, ranking 281 out of 385 in the Biotechnology & Medical Research industry with a current financial score of 6.19. Despite this, its latest quarterly revenue increased by 37.18% year-over-year to $2.00M, …

Clarivate (NYSE:CLVT) Trading Up 7.3% - Here's What Happened

Clarivate (NYSE:CLVT) shares rose 7.3% in midday trading on Tuesday but traded on significantly reduced volume. Despite beating earnings expectations and some analyst price target increases, the stock maintains a consensus "Reduce" rating from analysts. The company reported a revenue decline year-over-year and remains …

Claritev Corporation Revenue Breakdown – NYSE:CTEV

Clarivate earnings up next: Value plan faces quarterly test By Investing.com

Clarivate (CLVT) is set to report second-quarter earnings, with investors focused on whether its "Value Creation Plan" is improving efficiency despite stagnant revenue. Analysts anticipate earnings of 18 cents per share on $589.7 million in revenue, a 5.1% year-over-year decline. The company's recent sale …

Kimberly-Clark Corp (KMB) Valuation: PE, PB & Fair Value Analysis

The article provides a valuation analysis of Kimberly-Clark Corp (KMB), noting its current valuation score of 8.26, which ranks 21 out of 34 in its industry. It highlights the company's P/E ratio of 17.46, indicating it is below its recent high and above its …

Kimberly-Clark Corp (KMB) Financial Health: Profitability & Balance Sheet Analysis

Kimberly-Clark Corp (KMB) currently holds a weak financial score of 6.82, ranking 24 out of 34 in its industry. The company's latest quarterly revenue decreased by 13.99% year-over-year, and its net profit saw a 17.28% year-over-year decline. Most specific financial metrics related to Quality …

Kimberly-Clark Corporation $KMB Shares Sold by Dai ichi Life Insurance Company Ltd

Dai ichi Life Insurance Company Ltd significantly reduced its stake in Kimberly-Clark Corporation by 69.9% in the first quarter, selling 14,555 shares. While Dai ichi Life Insurance decreased its holdings, other institutional investors like Ally Financial Inc., Westpac Banking Corp, and Massachusetts Financial Services …

CLAR|Clarus Corp|Price:3.275|Chg%:+0.015

Clarus Corp (CLAR) is trading at $3.275, up 0.46%, with a market cap of $125.93M. The company's fundamentals are strong, and its valuation is seen as fairly valued within the Leisure Products industry. Analysts currently rate the stock as "Hold" with a target price …